Skip to main content
. 2024 May 15;72(4):776–787. doi: 10.1007/s12026-024-09484-7

Fig. 3.

Fig. 3

Treatment effect on imaging outcomes of imiquimod challenge. Basal flow (AU) (a), flare (AU) (b) and erythema (AU) (c) of imiquimod-treated skin during the imiquimod challenge, measured by laser speckle contrast imaging (LSCI) and multispectral imaging. Mean (standard deviation). AU arbitrary unit. p-values refer to the following contrasts: upper p-value EDP1815 overall vs placebo; EC1 EDP1815-EC1 vs placebo; EC2 EDP1815-EC2 vs placebo